Chapter

Adjuvant therapy for head and neck malignancy

Charles G. Kelly

in Oxford Textbook of Anaesthesia for Oral and Maxillofacial Surgery

Published on behalf of Oxford University Press

Published in print June 2010 | ISBN: 9780199564217
Published online July 2011 | e-ISBN: 9780199697854 | DOI: http://dx.doi.org/10.1093/med/9780199564217.003.0017

Series: Oxford Textbook in Anaesthesia

 Adjuvant therapy for head and neck malignancy

Show Summary Details

Preview

The non-surgical management of oral and oropharyngeal (OMF) tumours and head and neck cancer in general has changed over the last decade, with the development of new radiotherapy technology and techniques. Novel chemotherapy drugs, chemotherapy regimens, and the use of biological agents have also been introduced. These changes have altered the patterns of morbidity and side effects of non-surgical treatments both in the acute treatment phase and with long-term effects but most importantly has been the overall change in approach to the management of head and neck cancer, with much greater emphasis on organ preservation and post-treatment function. Presurgical adjuvant therapy is becoming increasingly common in the management of malignancy. This chapter describes the radio- and chemotherapeutic treatments for oral and maxillofacial malignancy and the consequences that are of most interest to the anaesthetist.

Chapter.  9357 words.  Illustrated.

Subjects: Anaesthetics

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.